| Completed | Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major S Factor 10 Deficiency | — | 2018-02-27 |
| Completed | Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects Healthy | Phase 2 / Phase 3 | 2017-12-08 |
| Completed | Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinaemia | Phase 3 | 2015-08-20 |
| Completed | A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children Factor X Deficiency | Phase 3 | 2015-04-01 |
| Terminated | Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemoph Haemophilia A | Phase 4 | 2014-11-21 |
| Completed | Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinaemia | Phase 3 | 2014-02-01 |
| Terminated | Safety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing Surgery Factor X Deficiency | Phase 3 | 2011-03-01 |
| Completed | A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinemia | Phase 4 | 2011-03-01 |
| Completed | A Study Investigating Treatment Factor X in People With Factor X Deficiency Factor X Deficiency | Phase 3 | 2010-01-01 |
| Completed | A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purp Chronic Idiopathic Thrombocytopenic Purpura | Phase 3 | 2007-09-01 |
| Terminated | Optivate in People With Von Willebrand Disease Undergoing Surgery Von Willebrand Disease | Phase 3 | 2007-02-01 |
| Terminated | A Study With OPTIVATE® in People With Von Willebrand Disease Von Willebrand Disease | Phase 3 | 2006-11-01 |
| Completed | Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. Primary Immunodeficiency, Common Variable Hypogammaglobulinemia, X-linked Hypogammaglobulinemia | Phase 3 | 2006-01-01 |
| Completed | An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Sur Haemophilia B | Phase 3 | 2005-12-01 |
| Completed | A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Y Haemophilia B | Phase 3 | 2005-08-01 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand vonWillebrand's Disease | Phase 2 | 2004-12-01 |
| Completed | A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Vol Healthy | Phase 1 | 2004-08-01 |
| Completed | A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Voluntee Healthy | Phase 1 | 2004-05-01 |
| Completed | A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia Haemophilia A | Phase 3 | 2003-11-01 |
| Completed | An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery Haemophilia A | Phase 3 | 2001-11-01 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemoph Von Willebrand Disease | Phase 3 | 2001-10-01 |
| Completed | An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients. Haemophilia A | Phase 3 | 2001-09-01 |
| Completed | A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Primary Antibody Deficiency | Phase 3 | 2000-06-01 |
| Completed | A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Sur Haemophilia B | Phase 3 | 2000-04-01 |
| Completed | A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency Primary or Secondary Antibody Deficiency | Phase 4 | 1999-04-01 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophi Haemophilia B | Phase 3 | 1997-07-01 |
| Completed | An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients Haemophilia B | Phase 3 | 1997-07-01 |